The Journal of Infectious DiseasesMicrobiologyPeer-reviewed journal article
Comprehensive Assessment of Initial Adaptation of ESBL Positive ST131 Escherichia coli to Carbapenem Exposure
William C. ShropshireiD, Xinhao SongiD, Jordan Bremer, Seokju SeoiD, Susana RodrigueziD, Selvalakshmi Selvaraj Anand, An Q. DinhiD, Micah M. BhattiiD, Anna KonovalovaiD, César A. AriasiD, Awdhesh KaliaiD, Yousif E. ShamooiD, Samuel A. ShelburneiD
Abstract
BackgroundIt remains unclear how high-risk Escherichia coli lineages, like sequence type (ST) 131, initially adapt to carbapenem exposure in their progression to becoming carbapenem resistant. MethodsCarbapenem mutation frequency was measured in multiple subclades of extended-spectrum {beta}-lactamase (ESBL) positive ST131 clinical isolates using a fluctuation assay followed by whole genome sequencing (WGS) characterization. Genomic, transcriptomic, and porin analyses of ST131 C2/H30Rx isolate, MB1860, under prolonged, increasing carbapenem exposure was performed using two distinct experimental evolutionary platforms to measure fast vs. slow adaptation. ResultsAll thirteen ESBL positive ST131 strains selected from a diverse (n=184) ST131 bacteremia cohort had detectable ertapenem (ETP) mutational frequencies with a statistically positive correlation between initial ESBL gene copy number and mutation frequency (r = 0.87, P-value <1e-5). WGS analysis of mutants showed initial response to ETP exposure resulted in significant increases in ESBL gene copy numbers or mutations in outer membrane porin (Omp) encoding genes in the absence of ESBL gene amplification with subclade specific associations. In both experimental evolutionary platforms, MB1860 responded to initial ETP exposure by increasing blaCTX-M-15 copy numbers via modular, insertion sequence 26 (IS26) mediated pseudocompound transposons (PCTns). Transposase activity driven by PCTn upregulation was a conserved expression signal in both experimental evolutionary platforms. Stable mutations in Omp encoding genes were detected only after prolonged increasing carbapenem exposure consistent with clinical observations. ConclusionsESBL gene amplification is a conserved response to initial carbapenem exposure, especially within the high-risk ST131 C2/H30Rx subclade. Targeting such amplification could assist with mitigating carbapenem resistance development.
- organism: E. coli
- assay: whole-genome sequencing
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 4
- FWCI
- 0.71
- Field percentile
- top 35%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Concurrence of Porin Loss and Modular Amplification of β-Lactamase Encoding Genes Drives Carbapenem Resistance in a Cohort of Recurrent Enterobacterales Bacteremia
William C. Shropshire, Samuel L Aitken, … Samuel A. Shelburne·Journal of Antimicrobial ChemotherapyPeer-reviewed·Oct 8, 2020
- Evolution of extended-spectrum β-lactamase-producing ST131 Escherichia coli at a single hospital over 15 years
S.-T. Cho, E. G. Mills, … D. Van Tyne·bioRxiv·Dec 11, 2023
- ompC/F mutations drive XDR phenotype and lineage defining super clones of E. coli: Sequential events and consequences
Naveen Kumar Devanga Ragupathi, Dhiviya Prabaa Muthuirulandi Sethuvel, … Balaji Veeraraghavan·bioRxiv·Jul 14, 2022
- Within-host succession from an OXA-48-like to an NDM-type carbapenemase in clonal ST361 Escherichia coli recovered from sequential urinary and bloodstream infection
Leon Kassabian, Charbel Al Khoury, … Sima T. Tokajian·bioRxiv·Jul 30, 2026
- Specificities and commonalities of carbapenemase producing Escherichia coli isolated in France from 2012 to 2015.
R. Patino-Navarrete, I. Rosinski-Chupin, … P. Glaser·bioRxiv·Oct 19, 2021
- Mapping the evolutionary path towards multi-drug resistance in the pandemic Escherichia coli ST131 lineage
Anna Kaarina Pöntinen, Nguyen Vinh Trung, … Jukka Corander·Microbial GenomicsPeer-reviewed·Sep 23, 2026